Pendulum: What You Need to Know
The short answer
Pendulum makes probiotics built around Akkermansia muciniphila and butyrate-producing gut bacteria. Its best-supported product is Glucose Control, which in one 12-week, company-run trial modestly improved after-meal blood sugar in adults with type 2 diabetes, though the A1C change narrowly missed statistical significance.
The single-strain Akkermansia product leans on preclinical studies and early human research that used a different preparation and dose. Pendulum is a reasonable thing to discuss with your doctor if you have type 2 diabetes. It is not a replacement for diabetes care, fiber-rich food or proven treatment.
Ultimate Gut is published by Ultimate Health Solutions, which sells a yogurt maker, probiotic capsules and an inulin fiber supplement. None of the products reviewed here are ours, and these brands don’t pay us.
What Pendulum sells and what’s in it
We read the product pages and label images for the two products most people search for, Pendulum Akkermansia and Pendulum Glucose Control (labels checked October 2026). Strain names below are exactly as labeled. Pendulum also sells other blends, such as Metabolic Daily, that we didn’t assess here.
| Product and ingredient (as labeled) | Amount per serving | Human research |
|---|---|---|
| Akkermansia: Akkermansia muciniphila WB-STR-0001 | 100 million AFU (1 capsule) | Pendulum cites preclinical studies for its gut-lining claims; the main human trial of A. muciniphila used other preparations at 10 billion bacteria a day |
| Akkermansia: chicory inulin | 276 mg | A prebiotic fiber; inulin is one of the dietary factors linked with more Akkermansia in a 2019 review of trials |
| Glucose Control: proprietary blend of Clostridium butyricum WB-STR-0006, Clostridium beijerinckii WB-STR-0005, Anaerobutyricum hallii WB-STR-0008, Akkermansia muciniphila WB-STR-0001, Bifidobacterium infantis | 2 billion AFU per dose (2 capsules); amount of each strain not disclosed | One 12-week randomized trial in 76 adults with type 2 diabetes, funded and run by Pendulum |
| Glucose Control: chicory inulin and oligofructose | Not disclosed | Part of the tested formula |
A few label details matter. The Akkermansia bottle carries a Supplement Facts panel, holds 30 servings and is stored at room temperature. Glucose Control carries a Nutrition Facts panel instead, holds 30 servings of 2 capsules, must be kept refrigerated and says to use it only under physician supervision as part of a diabetes management plan. Pendulum counts bacteria in AFU, a different unit from the bacterial counts used in most research, so doses can’t be compared one to one.
What Pendulum claims vs what the evidence shows
Glucose Control and the 2020 trial
Pendulum’s Glucose Control page says the product lowered A1C by 0.6 and after-meal glucose spikes by 32.5%, citing Perraudeau et al. 2020 in BMJ Open Diabetes Research & Care. Here is what that paper reports:
- Design: 76 adults with type 2 diabetes at six US sites were randomized to placebo (26), a three-strain formula (27) or the five-strain formula, WBF-011, that Pendulum cites for Glucose Control (23) for 12 weeks. Most were already taking metformin.
- Main result: the five-strain group improved on the primary outcome, total blood glucose over three hours after a test meal, by 36.1 mg/dL/180 min versus placebo (p = 0.05, right at the usual cutoff).
- A1C: 0.6 lower than placebo (p = 0.054). That gap came from a 0.2 drop in the probiotic group plus a 0.4 rise in the placebo group.
- The 32.5% figure: the median within-group drop in the incremental glucose curve after the test meal, not a cut in everyday blood sugar.
- Limits the authors list: small size, and more dropouts on placebo (10) than on the five-strain formula (2), which left 16, 21 and 21 people in the main analysis.
- Funding: no outside grant; all authors were employees and shareholders of Pendulum.
That is a real, placebo-controlled signal, which many probiotics lack. It is also one small proof-of-concept trial run by the company that sells the product, and it needs independent replication.
Akkermansia and “gut lining” claims
The Akkermansia page says the product fortifies the gut lining and reduces permeability, and footnotes those statements as based on preclinical studies. Its percentages for better gut health, regularity and fewer cravings come from consumer surveys of 172 and 80 people, not controlled trials. A Pendulum-funded study in rats found no toxicity from its Akkermansia powder over 90 days, which speaks to safety, not benefit.
The best-known human trial is Depommier et al. 2019 in Nature Medicine: 40 overweight or obese adults with insulin resistance enrolled and 32 finished three months of 10 billion A. muciniphila bacteria a day, live or pasteurized, or placebo. The clearest improvements, in insulin sensitivity, insulin levels and total cholesterol, came with the pasteurized form; weight changes were small and not statistically significant. Pendulum sells a live strain labeled at 100 million AFU, a different unit and preparation, so these results don’t transfer directly. A 2022 review by leading Akkermansia researchers notes that most evidence still comes from associations and animal models.
One more caution: one of Pendulum’s own product images says Akkermansia is “not intended for weight loss,” even though the page also talks about cravings.
FDA status
Pendulum Akkermansia is sold as a dietary supplement. The FDA does not have the authority to approve supplements for safety and effectiveness before they are sold.
Glucose Control is labeled for “the nutritional management of type 2 diabetes” under physician supervision, wording associated with medical foods, which the FDA defines as foods used under a physician’s supervision for the dietary management of a disease with distinctive nutritional requirements. In its 2023 medical foods guidance, which is nonbinding, the FDA says it does not consider diabetes a condition for which a medical food could be labeled and marketed. How that applies to any one product is the FDA’s call; we’re reporting what the documents say.
Price per serving
Both labels show 30 servings. In October 2026 Pendulum’s product pages listed Akkermansia at $54 for a one-month supply, about $1.80 per capsule, and Glucose Control at $99 for a one-month supply, about $3.30 per two-capsule serving. Membership, multi-month and promotional pricing change these figures, so check the page before ordering.
Who it may suit and who should skip it
It may suit you if:
- You have type 2 diabetes, your treatment is stable, and you and your doctor want to try an add-on with one randomized trial behind it.
- You are curious about Akkermansia, understand the evidence is early and are comfortable with the cost.
Skip it, or talk to a doctor first, if:
- You take diabetes medicines. Glucose Control’s label calls for physician supervision, and any change in blood sugar should be tracked with your care team. Never cut back medication on your own.
- You are seriously ill or immunocompromised. The NCCIH says the risk of harmful effects from probiotics is greater in people with severe illnesses or weakened immune systems.
- You are pregnant or breastfeeding. Pendulum’s FAQ says Akkermansia hasn’t been studied in pregnant or breastfeeding women.
- You want weight loss. That isn’t what the products are labeled for.
Pendulum’s FAQ also notes that some people get gas, bloating, nausea or loose stools in the first two weeks.
Alternatives, including food

Feed the Akkermansia you already have. A 2019 systematic review of 29 dietary trials (1,444 people) found that calorie restriction and supplements of pomegranate extract, resveratrol, inulin and a few other fibers raised A. muciniphila levels in some studies, while a low-FODMAP diet lowered them. The authors say more research is needed. A 2022 review adds that polyphenols such as anthocyanins and flavan-3-ols raise Akkermansia in animal and some human studies, with responses varying by person; one author founded an Akkermansia company.
Akkermansia is also a marker, not just a target. In a French study of 49 overweight adults, people with more Akkermansia at the start had healthier blood sugar and fat distribution and did better on a calorie-restricted diet. That is an association, not proof that adding it causes the benefit.
Fiber and fermented foods. In a Stanford trial of 36 healthy adults, a 10-week diet rich in fermented foods, including yogurt, kefir and kimchi, increased microbiome diversity and lowered inflammatory markers. Our guides to fiber supplements, probiotic foods and yogurt for probiotics cover practical options, and kefir is another live-culture food.
Other probiotics. If a general probiotic is what you’re after, our best probiotic comparison ranks strains by the human evidence for specific needs.
This article is general information, not medical advice.
Related topics
- Best Probiotic: strains matched to the evidence for each need.
- Fiber Supplement: how inulin and other fibers compare.
- Seed Probiotics: another premium probiotic brand assessed from its label.
- Probiotic Foods: food sources of live cultures.
- Best Probiotic for Weight Loss: what the research does and doesn’t show.
Sources
- Pendulum Akkermansia product page and label (Pendulum Therapeutics, checked October 2026)
- Pendulum Glucose Control product page and label (Pendulum Therapeutics, checked October 2026)
- Perraudeau F, et al. Improvements to postprandial glucose control in subjects with type 2 diabetes: a multicenter, double blind, randomized placebo-controlled trial of a novel probiotic formulation (BMJ Open Diabetes Research & Care, 2020)
- Depommier C, et al. Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study (Nature Medicine, 2019)
- Cani PD, et al. Akkermansia muciniphila: paradigm for next-generation beneficial microorganisms (Nature Reviews Gastroenterology & Hepatology, 2022)
- Yu E, et al. Lack of genotoxicity and subchronic toxicity in safety assessment studies of Akkermansia muciniphila formulation (Toxicology Reports, 2024)
- FDA 101: Dietary Supplements (U.S. Food and Drug Administration)
- Medical Foods Guidance Documents & Regulatory Information (U.S. Food and Drug Administration)
- Frequently Asked Questions About Medical Foods; Third Edition (U.S. Food and Drug Administration, 2023)
- Probiotics: Usefulness and Safety (National Center for Complementary and Integrative Health)
- Verhoog S, et al. Dietary factors and modulation of bacteria strains of Akkermansia muciniphila and Faecalibacterium prausnitzii: a systematic review (Nutrients, 2019)
- Rodríguez-Daza MC, de Vos WM. Polyphenols as drivers of a homeostatic gut microecology and immuno-metabolic traits of Akkermansia muciniphila: from mouse to man (International Journal of Molecular Sciences, 2022)
- Dao MC, et al. Akkermansia muciniphila and improved metabolic health during a dietary intervention in obesity (Gut, 2016)
- Fermented-food diet increases microbiome diversity, decreases inflammatory proteins, study finds (Stanford Medicine, 2021)
- Wastyk HC, et al. Gut-microbiota-targeted diets modulate human immune status (Cell, 2021)
This article is for general information and is not medical advice. Talk to your doctor or a registered dietitian before changing your diet, supplements or medication, especially if you have a health condition.
